{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
BioRestorative Therapies, Inc.
Is BioRestorative Therapies, Inc. technically bullish or bearish?
As of June 20, 2025, BioRestorative Therapies, Inc. exhibits a neutral technical trend with mixed signals, showing a recent 1.23% weekly gain but a concerning -19.21% return over the past year.
What does BioRestorative Therapies, Inc. do?
BioRestorative Therapies, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $0 million and a net loss of $5 million as of March 2025. The company has a market cap of $12.91 million and no dividend yield.
How big is BioRestorative Therapies, Inc.?
As of Jun 18, BioRestorative Therapies, Inc. has a market capitalization of 12.91 million, with net sales of 0.39 million and a net profit of -12.10 million over the last four quarters. The company's shareholder's funds are 8.53 million, and total assets amount to 12.28 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
